pentoxifylline has been researched along with Asthenia in 1 studies
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
Excerpt | Relevance | Reference |
---|---|---|
"The early inclusion of patients with NAFLD and severe asthenic syndrome in the treatment regimen, in addition to the basic therapy of Cytoflavin, achieved a significantly high therapeutic effect in the form of normalization of the main clinical, laboratory and instrumental parameters, as well as a significant reduction in the manifestations of asthenia." | 1.62 | [Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome]. ( Eremin, MN; Ivolgin, AF; Karakozov, AG; Katenko, SV; Levchenko, OB; Molodova, AI; Pavlov, AI, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Pavlov, AI | 1 |
Ivolgin, AF | 1 |
Katenko, SV | 1 |
Eremin, MN | 1 |
Molodova, AI | 1 |
Levchenko, OB | 1 |
Karakozov, AG | 1 |
1 other study available for pentoxifylline and Asthenia
Article | Year |
---|---|
[Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome].
Topics: Asthenia; Humans; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Saline Solution; Syndrome | 2021 |